Sort
11,323 grants matching “glioblastoma”
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$522,676Jonathan A Winger · Omniox, Inc. · R01 · FY2022 · CA
Targeting Glioblastoma Using Novel Small Molecule HIF-1 Pathway Inhibitors
$522,611Erwin G Van Meir · Emory University · R01 · FY2009 · CA
Flow-informed therapy for glioblastoma
$522,491Jennifer M Munson · Virginia Polytechnic Inst And St Univ · U01 · FY2025 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$522,189David M. Ashley · Duke University · U19 · FY2022 · CA
Translational Immunology
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Rare Central Nervous System Cancers Initiative
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$521,931Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
$521,277Isabel Kurth · Rgenix, Inc. · R44 · FY2017 · CA
Pre-Clinical Trials of GEM Models for Gliomas
$521,230Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
$521,167Michael D Gunn · Duke University · P01 · FY2020 · CA
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma
$521,070Honggang Cui · Johns Hopkins University · R01 · FY2023 · CA
Regulation of Centromere Protein Stability and Impact on Cancer Progression
$520,945Gary H. Karpen · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2016 · GM
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
$520,925Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2022 · NS
Understanding EGF receptor activation by growth factors and oncogenic mutations
$520,743Mark A. Lemmon · Yale University · R01 · FY2022 · CA
Master Regulatory MicroRNAs in Glioblastoma
$520,718Roger Abounader · University Of Virginia · U01 · FY2020 · CA
Developing new therapeutic strategies for brain metastasis
$520,544Eva Hernando · New York University School Of Medicine · R01 · FY2024 · CA
Understanding EGF receptor activation by growth factors and oncogenic mutations
$520,420Mark A. Lemmon · Yale University · R01 · FY2018 · CA
Regulatory Network Differences/Diverse Tumor Subtypes/Design Combinatorial Therap
$520,350Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
$520,200Christa Joy Nehs · Massachusetts General Hospital · R01 · FY2025 · AG
Canine Immuno Neurotherapeutics
$520,152M R Chambers · University Of Alabama At Birmingham · U01 · FY2020 · CA
Canine Immuno Neurotherapeutics
$520,152M R Chambers · University Of Alabama At Birmingham · U01 · FY2021 · CA
Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy
$520,099Noemi Andor · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Systems Biology of Tumor Progression and Drug Resistance
$520,000Andrea Califano · Columbia University Health Sciences · U01 · FY2013 · CA
Characterization of Lamprey B cells and Antibodies
$519,925Max D Cooper · Emory University · R01 · FY2025 · AI